IPO date
June 20, 2014
Total splits
2
Cumulative multiple
0.05
Split likelihood
Watch
Stock splits history for Relmada Therapeutics (RLMD) from 2015 to 2019
Cumulative multiple is the running product of split factors from the oldest row through each date.
| Type | Ratio | Pre-split | Post-split | |||
|---|---|---|---|---|---|---|
| September 30, 2019 | Reverse stock split | 1:4 | x0.25 | x0.05 | $0.52 | $2.30 |
| August 12, 2015 | Reverse stock split | 1:5 | x0.2 | x0.2 | $0.27 | $1.35 |
- September 30, 2019x0.05
- August 12, 2015x0.2
Pre-split price is the final regular-session close on a trading day strictly before the split calendar date. Post-split price is the first session open on or after that date. Both values come from unadjusted end-of-day bars for the company's primary listing.
The Type column reflects the data feed's event category (for example stock split vs stock dividend). When the feed labels a generic split but the ratio is reverse (e.g. 1:10), we show reverse stock split. Optional editorial context for a row appears next to the split ratio as an info icon (hover or keyboard focus on desktop; tap on mobile). The same text is listed under Row notes when that block is expanded.
Wondering why some rows show ratios like 51:50 or 2000:1973? Read: stock split ratios explained → How the cumulative column is computed: cumulative split multiplier explained. For ratios driven by spin-offs, see spin-offs explained. Or read the methodology for how prices and cumulative multiples are computed.
Split likelihood score for Relmada Therapeutics (RLMD)
Computed through June 13, 2026.
| Factor | Detail | Contribution |
|---|---|---|
| Absolute price | Price $6.65 → 8% of the price band | +4 |
| Personal split threshold | No prior forward split to anchor a personal threshold | n/a |
| Split track record | 2 prior splits on record | +17 |
| Proximity to 52-week high | Price is 83% of the 52-week high | +8 |
An educational, rule-based score — not a prediction of any split and not investment advice. Splits are at the sole discretion of a company's board. How it's calculated · Will a stock split?
Stock splits — Healthcare
Healthcare peers of Relmada Therapeutics, Inc. (RLMD), sorted by number of splits.
Frequently asked questions
Relmada Therapeutics (RLMD) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation